PL2091537T3 - Kompozycja farmaceutyczna do leczenia arteriopatii włośniczkowej - Google Patents

Kompozycja farmaceutyczna do leczenia arteriopatii włośniczkowej

Info

Publication number
PL2091537T3
PL2091537T3 PL07846885T PL07846885T PL2091537T3 PL 2091537 T3 PL2091537 T3 PL 2091537T3 PL 07846885 T PL07846885 T PL 07846885T PL 07846885 T PL07846885 T PL 07846885T PL 2091537 T3 PL2091537 T3 PL 2091537T3
Authority
PL
Poland
Prior art keywords
treatment
pharmaceutical compositions
capillary arteriopathy
arteriopathy
capillary
Prior art date
Application number
PL07846885T
Other languages
English (en)
Inventor
Rudolf Reiter
Johannes Tack
Reinhard Horowski
Original Assignee
Sinoxa Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinoxa Pharma Gmbh filed Critical Sinoxa Pharma Gmbh
Publication of PL2091537T3 publication Critical patent/PL2091537T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL07846885T 2006-11-23 2007-11-23 Kompozycja farmaceutyczna do leczenia arteriopatii włośniczkowej PL2091537T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06024308 2006-11-23
EP06025263 2006-12-06
EP07846885.7A EP2091537B1 (de) 2006-11-23 2007-11-23 Pharmazeutische zusammensetzungen zur behandlung von kapillarer arteriopathie
PCT/EP2007/010360 WO2008061805A1 (de) 2006-11-23 2007-11-23 Pharmazeutische zusammensetzungen zur behandlung von kapillarer arteriopathie

Publications (1)

Publication Number Publication Date
PL2091537T3 true PL2091537T3 (pl) 2013-10-31

Family

ID=38982525

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07846885T PL2091537T3 (pl) 2006-11-23 2007-11-23 Kompozycja farmaceutyczna do leczenia arteriopatii włośniczkowej

Country Status (14)

Country Link
US (2) US20090325997A1 (pl)
EP (1) EP2091537B1 (pl)
JP (1) JP5407865B2 (pl)
AU (1) AU2007324706B2 (pl)
CA (1) CA2670846C (pl)
CY (1) CY1114364T1 (pl)
DK (1) DK2091537T3 (pl)
ES (1) ES2425581T3 (pl)
HR (1) HRP20130791T1 (pl)
PL (1) PL2091537T3 (pl)
PT (1) PT2091537E (pl)
RU (1) RU2463048C2 (pl)
SI (1) SI2091537T1 (pl)
WO (1) WO2008061805A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103476402A (zh) * 2010-11-11 2013-12-25 西诺克萨医药有限公司 用于预防和/或治疗纤维化病变的麦角乙脲、特麦角脲及其衍生物
DE102010051391A1 (de) 2010-11-11 2012-10-11 Sinoxa Pharma Ug Multivalente Arzneistoffe mit kombinierter antioxidativer Wirkung und antagonistischen Effekten an 5-HT2-Rezeptor-Subtypen zur Behandlung von fibrotischem Organumbau.
EP2550959A1 (de) 2011-07-27 2013-01-30 Sinoxa Pharma Lisurid, Tergurid und Derivate davon zur Verwendung in der Prophylaxe und/oder Therapie fibrotischer Veränderungen
RU2516921C1 (ru) * 2013-04-08 2014-05-20 Общество с ограниченной ответственностью "Научно-производственная компания ВИТАФОРМ" Композиция для костной пластики (варианты)
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
US10849903B2 (en) * 2016-10-20 2020-12-01 Pfizer Inc. Anti-proliferative agents for treating PAH
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
WO2023107931A1 (en) * 2021-12-06 2023-06-15 Terran Biosciences, Inc. Salt and solid forms of indole analogs and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
EP1438019A1 (en) * 2001-10-24 2004-07-21 PARI GmbH Spezialisten für effektive Inhalation Kit for the preparation of a pharmaceutical composition
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN103476402A (zh) * 2010-11-11 2013-12-25 西诺克萨医药有限公司 用于预防和/或治疗纤维化病变的麦角乙脲、特麦角脲及其衍生物

Also Published As

Publication number Publication date
HRP20130791T1 (en) 2013-09-30
JP2010510273A (ja) 2010-04-02
DK2091537T3 (da) 2013-08-26
AU2007324706A1 (en) 2008-05-29
CA2670846C (en) 2014-12-23
ES2425581T3 (es) 2013-10-16
US20090325997A1 (en) 2009-12-31
PT2091537E (pt) 2013-08-29
SI2091537T1 (sl) 2013-10-30
CY1114364T1 (el) 2016-08-31
AU2007324706B2 (en) 2013-09-05
EP2091537A1 (de) 2009-08-26
RU2009123401A (ru) 2010-12-27
RU2463048C2 (ru) 2012-10-10
WO2008061805A1 (de) 2008-05-29
CA2670846A1 (en) 2008-05-29
US20140045879A1 (en) 2014-02-13
AU2007324706A2 (en) 2009-06-25
JP5407865B2 (ja) 2014-02-05
EP2091537B1 (de) 2013-05-22
US9695173B2 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL194176A0 (en) Pharmaceutical compositions
LT2478907T (lt) Kompozicijos vėžiui gydyti
IL198380A0 (en) Gas-enriched fluid compositions for wound healing
GB0713625D0 (en) Pharmaceutical compositions
ZA200900347B (en) Preparation of pharmaceutical compositions
ZA200808530B (en) Pharmaceutical composition for external use
ZA200808531B (en) Pharmaceutical composition for external use
SI2124556T1 (sl) Farmacevtske sestave
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL197235A0 (en) Therapeutic compositions
SI2091537T1 (sl) Farmacevtski sestavki za zdravljenje kapilarne arteriopatije
IL209360A (en) Medications containing pm00104 for the treatment of multiple myeloma
EP2114374A4 (en) PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE
GB0610322D0 (en) Novel pharmaceutical compositions
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
IL194066A0 (en) Therapeutic composition for treatment of tinnitus
IL176303A0 (en) Pharmaceutical composition for the treatment of otomycosis
ZA200807154B (en) Liquid treatment composition
GB0619891D0 (en) Pharmaceutical composition of risedronate
HUP0500947A2 (en) Composition for treatment of paradontosis